Helichuangxing Group
Overview
Helichuangxing Group is a Chinese conglomerate with investments in various sectors, including biotechnology. The company has a diverse portfolio spanning multiple industries, reflecting its broad investment strategy. Its focus on biotechnology underscores its commitment to advancing healthcare and related technologies. The group's investment approach encompasses a range of stages, from early-stage ventures to growth and late-stage investments. This strategy allows Helichuangxing Group to support companies at different phases of development, fostering innovation and expansion across its portfolio. With a substantial track record, Helichuangxing Group has demonstrated a consistent ability to identify and nurture promising enterprises. Its investments have contributed to the growth and success of numerous companies, solidifying its reputation as a significant player in the investment landscape.
Reach Helichuangxing Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Helichuangxing Group
What sectors does Helichuangxing Group invest in?
Helichuangxing Group invests in Financial Services, Healthcare, Consumer Goods, Real Estate, Telecommunications and Media, and is based in Anhui, China. Helichuangxing Group is listed as a corporate vc in the ConnectSafely investor database.
What stage does Helichuangxing Group invest at?
Helichuangxing Group backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Helichuangxing Group invest in?
Helichuangxing Group invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Last updated · Source: ConnectSafely investor database
